Merck and AstraZeneca Provide Update on US Regulatory Review of LYNPARZA® for Use in Combination With Abiraterone and Prednisone or Prednisolone for the Treatment of Metastatic Castration-Resistant Prostate Cancer Life Science Investing
Resverlogix Announces New Research Highlighting Apabetalone's Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19 Life Science Investing
The Bristol Myers Squibb-Janssen Collaboration Launches Pivotal Phase 3 Librexia Clinical Trial Program Evaluating Milvexian, an Investigational Oral Factor XIa Inhibitor Pharmaceutical Investing
Chronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip! Pharmaceutical Investing
BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference Pharmaceutical Investing
Merck Announces Phase 3 KEYNOTE-671 Trial Met Primary Endpoint of Event-Free Survival in Patients With Resectable Stage II, IIIA or IIIB Non-Small Cell Lung Cancer Life Science Investing
Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older Adults Life Science Investing
